TRANSITIONAL CAREER DEVELOPMENT AWARD IN WOMEN’S HEALTH RESEARCH Release Date: January 14, 2000 RFA NUMBER: OD-00-003 National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Cancer Institute National Institute of Child Health and Human Development National Institute of Dental and Craniofacial Research National Institute on Drug Abuse National Institute of Environmental Health Sciences National Heart, Lung, and Blood Institute National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research Office of Research on Women's Health Foundation for the National Institutes of Health Pfizer Women's Health, Pfizer Inc National Foundation for Biomedical Research PURPOSE The NIH Office of Research on Women's Health (ORWH) invites applications for the Transitional Career Development Award in Women's Health Research. This award is designed to support career development experiences leading to independence for clinical investigators interested in patient-oriented or population-based research related to women's health. The career development program will provide an opportunity for investigators to develop solid clinical research skills during two years of study and research within the environment of the NIH Intramural Research Programs (IRP). The award will also include a follow-on two-year period of salary and research support at an academic institution of the candidate's choice. This period of extramural support will facilitate the transition to independence as a clinical researcher specializing in research issues related to women's health. Salary support for the intramural phase of the program will be provided by Pfizer Women's Health of Pfizer Inc through a grant to the Foundation for the National Institutes of Health (FNIH). During this two-year period of career development, the candidate will engage in supervised clinical research and career development as a clinical or research fellow in the IRP of one of the NIH Institutes or Centers. Research support for this segment of the award will be provided by the assigned NIH Institute or Center. For the second phase of the award, research and salary support will be provided by ORWH in the form of an extramural career development award (K22) administered by the assigned NIH Institute or Center. The career development award will be activated when the candidate has assumed a suitable, independent research position at an academic institution. Diseases of women of particular interest include therapeutic areas identified at the Beyond Hunt Valley Conference (http://www4.od.nih.gov/orwh/orwhpubs.html) sponsored by the Office of Research on Women's Health. This conference designed a research agenda for women's health in the 21st century. Research projects should investigate the presentation, clinical course and/or management of any of the cardiovascular, cancer, metabolic, gastroenterologic, urologic, musculoskeletal, neuroendocrine, mental, infectious, or autoimmune diseases or any other medical conditions which occur with higher prevalence in women. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This Request for Applications (RFA), Transitional Career Development Award in Women's Health Research, is related to one or more of the priority areas. Potential applicants may obtain a copy of "Healthy People 2000" at http://odphp.osophs.dhhs.gov/pubs/hp2000. ELIGIBILITY REQUIREMENTS Individuals must have a health-professional doctoral degree or its equivalent and must be able to demonstrate the potential for highly productive patient- oriented research. Individuals with the MD, MD-PhD, DO, DDS, Pharm.D-MS, Pharm.D-PhD, RN-PhD, or comparable clinical or combined clinical/research degrees are eligible to apply. In most cases, applicants will have finished their clinical training and will have had some research experience in either a laboratory or clinical setting. Candidates should possess aptitudes for independent, patient-oriented or population-based research (e.g. epidemiology, behavior, or disease prevention) and should be able to demonstrate a commitment to the study of diseases that occur in women. Candidates must be able to demonstrate that after two years of supervised research and study at the NIH they will have the capacity to reach a level of competency necessary for independent research support. Former or current principal investigators on National Institutes of Health (NIH) research project grants (P01, R01, R29), SBIR/STTR awards (R43, R44/R41, R42), center grants (P30, P50), subprojects of program project or center grants, career awards (K07, K08, K23, K24), or the equivalent are not eligible. Clinical fellows working in NIH intramural laboratories who meet the other eligibility requirements are eligible to apply. During the intramural phase, the Transitional Career Awardee is expected to spend full time on research and research-related activities. During the extramural phase, the Transitional Awardee must spend at least 75% of his/her full-time professional effort conducting research or engaged in research career development activities. Before submitting an application for the Transitional Career Award, the candidate must identify a researcher within the NIH IRP who will serve as the sponsor/mentor and will be committed to supervising the candidate and supervising her/his research and career development during the first phase of this award. A list of potential sponsors within the IRP is available at http://grants.nih.gov/training/transitional_award.htm. The sponsor must be an active investigator in the area of the proposed research and must provide evidence of successful mentoring of comparable clinical trainees. Further, the sponsor must be able to provide the non-salary resources necessary for the proposed research and career development experience. All applicants are encouraged to contact the ORWH staff listed at the end of this announcement for information regarding their eligibility for this award prior to preparing an application. Racial/ethnic minority individuals, women, and persons with disabilities are encouraged to apply as Principal Investigators. Candidates must be U.S. citizens or non-citizen nationals, or must have been lawfully admitted for permanent residence and possess an Alien Registration Card (I-151 or I-152) or some other verification of legal admission as a permanent U.S. resident, at the time of the award. Non-citizen nationals, although not U.S. citizens, are individuals who owe permanent allegiance to the U.S. They are usually born in lands that are not states, but are under U.S. sovereignty, jurisdiction, or administration. Individuals on temporary or student visas are not eligible to apply. MECHANISM OF SUPPORT The Transitional Program will use the NIH Career Transition Award (K22) mechanism. The planning, direction, and execution of the program will be the responsibility of the candidate and her/his mentor on behalf of NIH IRP in the first phase and the awardee institution on behalf of the candidate in the second phase. The total period of support for the Transitional Career Development Award is four years. The program begins with two years of support for the Transitional Awardee's research training in the NIH intramural research environment. Salary costs for this phase will be derived from a grant from Pfizer Women's Health to the Foundation for the National Institutes of Health. Research costs will be provided by the NIH Institute which supports the sponsor's laboratory. There is no extramural grant award associated with the intramural phase. If additional time is required for the intramural phase of the award period, all costs will be covered by the sponsoring NIH institute. The final two years of the Transitional Career Development Award will be supported by the ORWH through the awarding NIH Institute or Center. The scholar will be funded through an extramural, non- competing, NIH Career Transition Award (K22). The award will be made in behalf of the candidate to the extramural institution in which the candidate secures a suitable research position. During the extramural phase of the Career Transition Award, the Transitional Career Awardee is encouraged to apply for additional independent research support. The Transitional Career Development Award is not renewable and not transferable to another investigator. During both the intramural and extramural phases of the award, candidates may be invited to attend Pfizer sponsored scientific conferences. Pfizer will provide support to cover costs associated with travel to these conferences. Candidates are required to acknowledge the source of support in any publication of findings that result from studies supported by this award (see the NIH Grants Policy Statement at http://grants.nih.gov/grants/policy/nihgps/part_ii_5.htm - rightsdata. FUNDS AVAILABLE A grant from Pfizer Women's Health to the Foundation for the National Institutes of Health will support the salary and fringe benefits for two Transitional Career Awardees during both years of career development within the NIH Intramural Programs. The participating research groups within the NIH Intramural Programs will provide research support for the awardees during that period. After the awardee is approved for transition to an extramural position, ORWH will provide continuing support for the two awardees for two additional years. Additional awards may be funded at the discretion of the participating NIH Institutes and Centers. RESEARCH OBJECTIVES The Transitional Career Development Award will provide salary and research support for the training of outstanding, patient-oriented researchers in the area of women's health. The program is uniquely designed to facilitate the transition of the candidate to an independent research career in the extramural research community. This program will provide an opportunity to develop clinical research skills within the highly regarded NIH intramural research program and will then facilitate the transition to a position as an independently funded investigator at an extramural institution. This is a novel opportunity for new exceptionally talented investigators to receive research training and establish an independent research program. The Transitional Awardees Program will also benefit the NIH by providing a cadre of new, creative junior scientists who will expand the collaborative research opportunities within the NIH Intramural Programs. ALLOWABLE COSTS Intramural Phase: A grant from Pfizer Women's Health will provide up to $100,000 per year to offset the intramural salary (or stipend) and fringe benefits for each successful candidate as well as the administrative fee for the Foundation for the National Institutes of Health. Grants from Pfizer Women's Health will support two candidates during both years of career development within the IRP. During this phase of the award, the candidate will be classified as a research fellow or clinical fellow within the IRP. The salary or stipend provided to the Transitional Career Awardee will be commensurate with the level of training, experience, and clinical responsibilities of the candidate. The salary and fringe benefits will be negotiated at the time of the award. Laboratory equipment purchased for the candidate during the intramural phase is not transferable to the extramural institution. The sponsoring NIH laboratory will support the research expenses, training costs, equipment, and travel. Extramural Phase: Support for the extramural phase of both recipients of the Transitional Career Award will be provided by ORWH and may not exceed $175,000 in direct costs per year for two years. 1. Salary: At the extramural institution, the Transitional Career Awardee will be provided with salary support plus fringe benefits. Salary requests should conform to the established, consistently applied policy of the institution for other staff members of equivalent qualifications, rank, and responsibilities. The total salary allowable must be based on a full-time, 12-month staff appointment for individuals of comparable rank and experience at that institution. In no case will the base salary provided by the award exceed the legislated maximum salary. The institution may supplement the NIH contribution. However, supplementation may not be from Federal funds unless specifically authorized by the Federal program from which such funds are derived. In no case may NIH funds be used for salary supplementation. Institutional supplementation of salary must not require extra duties or responsibilities that would interfere with the purpose of this award. During the extramural phase, the candidate must devote at least 75 percent effort to the proposed research and research career development program. 2. Research support: Award amounts above the salary costs can be used to support research expenses such as supplies, equipment, consultants, patient care costs, technical personnel, travel to research meetings or training, and statistical services. 3. Ancillary Personnel Support: Salary for secretarial and administrative assistance is not allowed. 4. Facilities and Administrative Costs: F&A costs will be reimbursed at eight percent of modified total direct costs. SPECIAL RESTRICTIONS The Transitional Award is specifically intended to help develop scientists who will pursue careers in the extramural biomedical research community. The expectation is that the Transitional Career Awardee will move to a tenure-track or equivalent position in the extramural biomedical research community for the final two years. However, the awardee is not explicitly precluded from applying for available tenure-track positions at the NIH. If the awardee obtains an NIH tenure-track or other NIH position, the Transitional Award will be terminated. INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of the NIH that women and members of minority groups and their subpopulations must be included in all NIH supported biomedical and behavioral research projects involving human subjects, unless a clear and compelling rationale and justification is provided that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This policy implements Section 492B of the Public health Service Act, as amended by the NIH Revitalization Act of 1993, Public Law 103-43. All investigators proposing research involving human subjects should read the "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research," which was published in the Federal Register of March 28, 1994 (FR 59 14508-14513) and in the NIH Guide for Grants and Contracts, Vol. 23, No. 11, March 18, 1994, available on the web at: http://grants.nih.gov/grants/guide/notice-files/not94-100.html. INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of NIH that children (i.e., individuals under the age of 21) must be included in all human subjects research, conducted or supported by the NIH, unless there are scientific and ethical reasons not to include them. This policy applies to all initial (Type 1) applications submitted for receipt dates after October 1, 1998. All investigators proposing research involving human subjects should read the "NIH Policy and Guidelines" on the Inclusion of Children as Participants in Research Involving Human Subjects that was published in the NIH Guide for Grants and Contracts, March 6, 1998, and is available at the following URL address: http://grants.nih.gov/grants/guide/notice-files/not98-024.html Investigators also may obtain copies of these policies from the program staff listed under INQUIRIES. Program staff may also provide additional relevant information concerning the policy. APPLICATION PROCEDURES Individuals interested in applying for the Transitional Award must identify a sponsor/mentor in NIH Intramural Research Programs (IRP). A list of such opportunities is available on the NIH website at http://grants.nih.gov/training/transitional_award.htm. The candidate must communicate directly with the identified sponsor whose research interest and training availability complements her/his own interests. The application is prepared in consultation with identified sponsor. A letter of support from the scientific director of the sponsoring laboratory or clinic must accompany the application. Submission Procedures: All candidates are strongly encouraged to contact the staff person in the ORWH and the relevant institute or center listed under INQUIRIES. Such contact should occur early in the planning phase of application preparation. Such contact will help ensure that applications are responsive to the goals and policies of the individual institute or center. Applications are to be submitted on the grant application form PHS 398 (revision 4/98) and should use the instructions in Section IV of the application kit. The application will be accepted on or before March 20, 2000. Forms are available at most institutional offices of sponsored research and from the Division of Extramural Outreach and Information Resources, National Institutes of Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, Phone (301) 435-0714, FAX: (301) 480-0525, Email: GrantsInfo@nih.gov. Forms are also available on the NIH Website at http://grants.nih.gov/grants/funding/phs398/phs398.html To identify the application as a response to this Request for Applications, check "YES" on item 2 of page 1 of the application and enter RFA-OD-00-003 "Transitional Career Development Award in Women's Health Research." The RFA label available in the PHS 398 (rev. 4/98) application form must be affixed to the bottom of the face page of the application. Failure to use this label could result in delayed processing of the application such that it may not reach the review committee in time for review. The sample RFA label available at: http://grants.nih.gov/grants/funding/phs398/label-bk.pdf has been modified to allow for this change. Please note this is in pdf format. Submit a signed, typewritten original of the application with Checklist, and four signed photocopies, in one package to: Center for Scientific Review National Institutes of Health 6701 Rockledge Drive, Room 1040 - MSC 7710 Bethesda, MD 20892-7710 or Bethesda, MD 20817-7710 (for express/courier service) Submit a single photocopy of the signed original application to: C. James Scheirer, Ph.D. Deputy Director, DEA and Chief, Review Branch National Heart, Lung, and Blood Institute, NIH Rockledge Building II, Room 7216 6701 Rockledge Drive Bethesda, MD 20892 Phone: (301) 435-0266 Fax: (301) 480-3541 E-mail: js110j@nih.gov Applicants are also encouraged to send one photocopy of the application to Dr. Ruth Merkatz, Pfizer Women's Health, Pfizer Inc., 235 East 42nd Street, New York, NY 10017 for informational purposes. Supplemental Application Guidelines: The initial application for the Transitional Career Development Award in Women's Health Research will not be processed through the individual's current institution. Therefore, these supplemental guidelines should be followed: Enter in item 6 (Dates of Proposed Period of Support) the combined years of support needed to complete the intramural and the extramural phases of the Transitional Awardees Program; Leave items 9-14 on the face page blank; Provide applicant's signature in item 15; A signature is not required for item 16; Do not submit a Checklist Page; The application must address the following issues: Candidate * Describe the candidate's commitment to a career in patient-oriented, women's health research; * Establish the candidate's potential to develop into a successful independent investigator; * Provide three sealed letters of recommendation addressing the candidate's potential for a productive and successful career in clinical research. It is recommended that one letter should be from the most recent mentor or supervisor in either a postdoctoral research or clinical setting or from the applicant's thesis advisor. These sealed letters must be attached to the face page of the original application. Career Development Plan: * Describe a career development plan incorporating the candidate's immediate and long-term career objectives and goals, explaining how the proposed program would contribute to their attainment; * Describe a systematic plan to obtain the necessary research experience to launch an independent research career in the area of women's health research. Plans for continued scientific development for a research career may include the need for any courses, training in research techniques or methods, etc.; * Describe plans to receive instruction in the responsible conduct of research. These plans must detail the proposed subject matter, format, frequency, and duration of instruction, as well as the amount and nature of senior staff participation. No award will be made if an application lacks this component. Candidates and the sponsor may wish to explore the availability of the following courses offered by the IRP: Introduction to the Principles and Practice of Clinical Research; the clinical electives program course on bioethics; and the ethics training provided by each individual institute or center. Sponsor's Statement: * Include information on the sponsor's research qualifications and previous experience as a postdoctoral mentor/supervisor; * Describe the nature and extent of the sponsor's commitment and supervision that will occur during the intramural phase of this program; * Describe the elements of research training planned for the candidate, including any formal courses for the candidate and demonstrate how these will promote the candidate's scientific independence. Intramural Environment and Institutional Commitment: * The sponsor should document a strong, well-established research program related to the candidate's area of interest, including an environment with staff capable of productive collaboration with the candidate; * Provide a statement from the Scientific Director of the NIH Intramural Research Program in support of the proposed career development experience and committing resources to foster the candidate's development into a productive, independent investigator if an award is made. Research Plan: * Describe the research plan as outlined in the PHS 398 application kit, "Research Career Award section". Include information on the hypothesis and specific aims, background, significance and rationale, preliminary studies and any results, and research design and methods. The candidate should consult with the sponsor regarding the development of the research proposal; * Describe research plans that are sufficient to justify two years of support in the intramural laboratory; * Provide future research directions for the extramural phase, i.e., what are the broad research goals and potential avenues of research that would be stimulated by the specific research project; * Relate the research plan to the candidate's career goals and career development plan. Budget: * Provide an estimated budget for the intramural phase of the award using the instructions in the PHS 398 application kit. The final budget will be negotiated when the candidate accepts the award. Award amounts provided will remain within the allowable costs specified above. Budget estimates for the extramural phase of the award do not need to be supplied at the time of application. Application Receipt Date: March 20, 2000 Peer Review: June, 2000 Council Review: September, 2000 Earliest Possible Start Date: September, 2000 REVIEW CONSIDERATIONS Upon receipt, applications will be reviewed by the CSR and other extramural staff for completeness and for responsiveness to this RFA. Applications that are incomplete and/or unresponsive will be returned to the applicant without further consideration. All applications considered to be complete and responsive will be evaluated for scientific and technical merit in accordance with the review criteria stated below by an initial peer review group (IRG) convened by the Scientific Review Branch, Division of Extramural Activities, National Heart, Lung, and Blood Institute. As part of the initial merit review, applications will receive a priority score and a written critique. In addition, applications will receive a second level of review by the advisory council or board of the sponsoring NIH Institute. Review Criteria The peer review criteria for applications submitted in response to this RFA are: Candidate * Potential to develop into a productive, independent scientist; * Commitment to a career in patient-oriented or population-based woman's health research; * Quality and breadth of prior scientific training and experience including, where appropriate, a record of previous research support and publications. Career Development Plan * Likelihood that the career development plan will contribute substantially to the scientific development of the candidate, considering the candidate's goals and prior experience; * Consistency of the career development plan for both the intramural and extramural phases and the stated career goals of the candidate; * Appropriateness of the plan to obtain training in the responsible conduct of research. Sponsor * Appropriateness of Intramural sponsor's research qualifications in the scientific area of this application and the sponsor's history of research productivity and support; * The level of commitment of the sponsor during the intramural phase of the award to career guidance and the development of the candidate's skills and knowledge; * Previous experience and success in fostering the development of young researchers; Research Plan * Consistency of the research plan and the candidate's level of research development and training; * Appropriateness of the research plan as a vehicle for developing the needed research skills; * Scientific and technical merit of the research question, design and methodology. * Relationship of the broad research goals and scientific directions for the extramural phase to the specific research project identified in the intramural phase; Institutional Commitment and Environment * Appropriateness of environment and the resources committed by the IRP to the candidate's research and career development. Budget * Justification of budget request for the intramural phase of the award in relation to needs of the research project and training activities proposed. AWARD CRITERIA The institute or center will notify the applicant of the board or council's action shortly after its meeting. Funding decisions will be made based on the recommendations of the initial review group and council/board, the need for research personnel in specific program areas, and the availability of funds. The progress of the candidate's research and career development will be monitored annually during the intramural phase of this award by a committee composed of representatives of Pfizer Women's Health and scientists from the relevant intramural and extramural NIH programs. The results of these formal reviews will be presented in writing to the Transitional Career Awardee, the sponsor within the IRP, and to extramural program staff within the NIH sponsoring/awarding Institute. Prior to activation of the extramural phase of the program, the Transitional Career Awardee must obtain a position as an independent researcher at an eligible, sponsoring extramural institution. The extramural institution must demonstrate a commitment to the Transitional Career Awardee by providing protected research time and sufficient space and resources needed to perform the proposed research. The candidate will describe plans for the research and career development at the extramural institution and will request a change of institution by submitting an abbreviated application using the career development sections of form PHS 398. This application must be received by the extramural program official at the sponsoring/ awarding NIH Institute at least four months prior to the beginning of the expected start date of the extramural phase. The information in this application along with the candidate's progress reports from the intramural phase will be used to determine the suitability of an extramural award. Disapproval of the extramural phase of the award may result in a terminal (third) year of NIH intramural support if approved by the NIH sponsoring/awarding institute or center. In cases of disapproval, no transition funding to the extramural environment will be provided. Approval of the transition to the extramural phase of the award can be made at any time prior to the end of the second year of intramural support. However, the maximum duration of the extramural phase will be two years and any remaining portion of the intramural phase will not be carried over into the extramural phase. INQUIRES Inquires are encouraged concerning this PA, especially during the planning phase of the application. The opportunity to clarify any issues or address questions from potential applicants is welcome. Address inquiries regarding programmatic issues to: National Institute on Aging Dr. Robin A. Barr Office of Extramural Affairs 7201 Wisconsin Avenue, Room 2C218, MSC 9205 Bethesda, MD 20892-9205 Telephone: (301) 496-9322 FAX: (301) 402-2945 Email: rb42h@nih.gov National Institute of Allergy and Infectious Diseases Dr. Milton Hernandez Office of Scientific Training and Manpower Development Solar Building, Room 3C21 Bethesda, MD 20892 Telephone: (301) 496-7291 FAX: (301) 402-0369 Email: mh35c@nih.gov National Institute on Arthritis and Musculoskeletal and Skin Diseases Richard W. Lymn, Ph.D. Research Training Officer National Institute of Arthritis and Musculoskeletal and Skin Diseases Building 45, Room 5AS-49E Bethesda, MD 20892-6500 Telephone: (301) 594-5128 FAX: (301) 480-4543 Email: richard_w_lymn@nih.gov National Cancer Institute Dr. Lester S. Gorelic or Dr. Andrew Vargosko National Cancer Institute Office of the Deputy Director for Extramural Sciences Office of Centers, Training and Resources Executive Plaza North, Room 520, MSC 7390 Bethesda, MD 20892-7390 Telephone: (301) 496-8580 FAX: (301) 402-4472 Email: lg2h@nih.gov or av8b@nih.gov National Institute of Child Health and Human Development Donna L. Vogel, M.D., Ph.D. Reproductive Sciences Branch Center for Population Research Building 6100, Room 8B01 MSC 7510 Bethesda, MD 20892-7510 Telephone: 301-496-6515 FAX: 301-496-0962 Email: dv1h@nih.gov National Institute on Dental and Craniofacial Research James A. Lipton, Ph.D. Special Assistant for Training and Career Development Natcher Building, Room 4AN.18J Bethesda, MD 20892-6402 Telephone: (301) 594-2618 FAX: (301) 480-8319 Email: liptonj@de45.nidcr.nih.gov National Institute on Drug Abuse Cora Lee Wetherington, Ph.D. Women and Gender Research Coordinator 6001 Executive Boulevard, Room 4282, MSC 9555 Bethesda, MD 20892-9555 Telephone: 301-443-1263 FAX: 301-594-6043 Email: wetherington@nih.gov National Institute of Environmental Health Sciences Dr. Carol Shreffler Division of Extramural Research and Training P. O. Box 12233 MD EC-23 Research Triangle Park, NC 27709 Telephone: (919) 541-1445 FAX: (919) 541-5064 Email: shreffl1@niehs.nih.gov National Heart, Lung, and Blood Institute Beth Schucker, M.A. National Heart, Lung, and Blood Institute Two Rockledge Center, Room 9206 6701 Rockledge Drive, MSC 7940 Bethesda, Maryland 20892-7940 Phone: (301) 435-0535 FAX: (301) 480-1454 E-mail: SchuckeB@nih.gov National Institute of Mental Health Mary C. Blehar, Ph.D. Chief, Women's Mental Health Program National Institute of Mental Health 6001 Executive Boulevard Room 8125, MSC 9569 Bethesda, Maryland 20892-9659 Phone: (301) 443-2847 FAX: (301) 443-8552 E-mail: BleharM@nih.gov National Institute of Neurological Disorders and Stroke Joseph S. Drage, M.D. Training and Special Programs Officer, OD, NINDS Neuroscience Center Room 3309 Bethesda, MD 20892-9531 Telephone: (301) 496-4188 FAX: 301-402-4370 Email: jd66x@nih.gov National Institute of Nursing Research Nell Armstrong, PhD, RN Program Director Division of Extramural Activities NINR/NIH Bethesda, MD 20892 Telephone: 301-594-5973 FAX: 301-480-8260 Email: nell_armstrong@nih.gov Office of Research on Women's Health Joyce Rudick Director, Programs and Management Office of Research on Women's Health Building 1, Room 201 9000 Rockville Pike Bethesda, MD 20892-0161 Phone: 301 402-1770 Fax: 301 402-1798 email: rudickj@od.nih.gov Foundation for the National Institutes of Health Theodore R. Colburn, Ph.D. Scientific Director Foundation for the National Institutes of Health, Inc. 1 Cloister Court, Suite 152 Bethesda, MD 20814-1460 Phone: 301-435-4686 Fax: 301-480-2752 email: tc7v@nih.gov AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance No. 93.867. Awards are made under the authority of Section 301, 405, 486, and 499 of the PHS Act as amended (Public Law 78-410, as amended, 42 USC 241, 284, 287d, and 290b). The Code of Federal Regulations, Title 42 Parts 52 and 63, and Title 45 Part 74, are applicable to this program. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. The Foundation for the National Institutes of Health, Inc. is an independent non-profit 501(c)(3) corporation established by Congress to support the mission of NIH. The Foundation's authorizing legislation permits the solicitation, receipt and management of grants from outside organizations to support NIH programs. The PHS strongly encourages all grant recipients to provide a smoke-free workplace and promote the non-use of tobacco products. In addition, Public Law 103-227, The Pro-Children Act of 1994, prohibits smoking in certain facilities (or, in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided for children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Return to NIH Guide Main Index
![]() |
Office of Extramural Research (OER) |
![]() |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
![]() |
Department of Health and Human Services (HHS) |
![]() |
||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |